Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03787602 |
|---|---|
| Brief Title: | Navtemadlin (KRT-232) With or Without Anti-PD-1/Anti-PD-L1 for the Treatment of Patients With Merkel Cell Carcinoma |
| First Submitted : | December 6, 2018 |
| First Submitted that Met QC Criteria : | December 21, 2018 |
| First Posted : | December 26, 2018 |
| Last Update Submitted that Met QC Criteria : | August 3, 2022 |
| Last Update Posted : | August 4, 2022 |